Judith Lacey
Judith Lacey/mylifehouse.org.au

Judith Lacey: Insights on Medicinal Cannabis and Adherence in Advanced Cancer at COSA 2025

Judith Lacey, Head of Supportive Care and Integrative Oncology at Chris O’Brien Lifehouse, shared a post on LinkedIn:

“Was great to participate today on what I thought was an excellent session lead by the oncology pharmacy COSA group. Featuring Dr Courtney Cross on the Microbiome and cancer supportive care, cancer related cognitive impairment and immunotherapy response and more, Nikola Bowden on repurposed drugs to enhance responsiveness to immunotherapy and resistant ovarian cancer, Lachlan Roth on the pharmacist role in caring for people with serious mental health concerns and I presented our work on adherence and patient perspective re medicinal cannabis in advanced cancer. Thanks to chairs Kimberley-Ann Kerr and Jenny Casanova.”

Judith Lacey

More posts featuring Judith Lacey on OncoDaily.

You Can Also Read: Colorectal Cancer and Cannabis: Who’s Winning the Battle for the Bowels?

Colorectal cancer and cannabis